| MCP | maximum closure pressure; maximum contraction pattern; malanocortin receptor; melphalan, cyclophosph... |
|---|---|
| MCPP | metacarpophalangeal pattern profile; metacarpophalangeal profile; meta-chlorophenylpiperazine |
| MCPPP | metacarpophalangeal pattern profile plot |
| MPB | male pattern baldness; meprobamate |
| PDP | pattern disruption point; piperidinopyrimidine; platelet-derived plasma; primer-dependent deoxynucle... |
| cell-mediated immunity | <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody. Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites. (26 Mar 1998) |
|---|---|
| cellular immunity | <cell biology, immunology> Immune response that involves enhanced activity by phagocytic cells and does not imply lymphocyte involvement. Since the term is easily confused with cell-mediated immunity its use in this sense should be avoided. (26 Mar 1998) |
| cellular immunity deficiency syndrome | <syndrome> A syndrome marked by increased susceptibility to infection, especially to viral infection, associated with defective functioning of the mechanism responsible for acquired immunity of the cell-mediated kind. See: immunodeficiency. (05 Mar 2000) |
| group immunity | <immunology> Resistance of a group to a pathogen due to immunity of a large proportion of the group to that pathogen. (09 Oct 1997) |
| concomitant immunity | The paradoxical immune status in which resistance to reinfection coincides with the persistence of the original infection. Synonym: concomitant immunity. (05 Mar 2000) |
| herd immunity | <immunology> Resistance of a group to a pathogen due to immunity of a large proportion of the group to that pathogen. (09 Oct 1997) |
| humoral immunity | <immunology> A form of immunity whereby B lymphocytes and plasma cells produce antibodies to foreign agents (antigens) and stimulate T lymphocytes to attack them (cellular immunity). These antibodies also stimulate the release of chemical mediators (for example interferon, complement) which enhance antigen destruction. (06 Mar 1998) |
| specific active immunity | See: acquired immunity. (05 Mar 2000) |
| specific immunity | The immune status in which there is an altered reactivity directed solely against the antigenic determinants (infectious agent or other) that stimulated it. See: acquired immunity. (05 Mar 2000) |
| specific passive immunity | See: acquired immunity. (05 Mar 2000) |
| natural immunity | This includes local barriers to infection such as skin, stomach acid, mucous, the cough reflex, enzymes in tears and saliva and skin oils. (27 Sep 1997) |
| natural passive immunity | Immunity conferred by the mother on the foetus or newborn. (14 Nov 1997) |
| stress immunity | Insusceptibility or resistance to the effects of emotional strain. (05 Mar 2000) |
| immunity | <immunology> The condition of being immune, the protection against infectious disease conferred either by the immune response generated by immunisation or previous infection or by other nonimmunologic factors. Origin: L. Immunitas (13 Oct 1997) |
| immunity, active | Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. (12 Dec 1998) |